Dysregulation of the OGF–OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat

Medicine & Life Sciences

• methionine-enkephalin receptor 83%
• Diabetes Complications 78%
• Type 1 Diabetes Mellitus 69%
• Opioid Analgesics 69%
• Intercellular Signaling Peptides and Proteins 63%
• Eye 48%
• Serum 35%
• Dry Eye Syndromes 31%
• growth inhibitory factor 30%
• Streptozocin 26%
• Naltrexone 24%
• Re-Epithelialization 17%
• Tears 12%
• Insulin 8%
• Corneal Injuries 8%
• Cell Proliferation 8%
• Corneal Epithelium 8%
• Animals 6%
• Hyperglycemia 5%
• Type 2 Diabetes Mellitus 4%
• Homeostasis 4%
• Animal Models 4%
• Injections 3%

Chemical Compounds

• Ocular 100%
• Growth Factor 91%
• Naltrexone 36%
• Serum Level 31%
• Surface 24%
• Surface Defect 18%
• Narcotic Antagonist 11%
• Abrasion 8%
• Insulin Derivative 7%
• Disorder 6%
• Block Like Crystal 5%